Similar articles

• Growth inhibition of human pancreatic cancer cells by human interferon-beta gene combined with gemcitabine.

  Endou M, Mizuno M, Nagata T, Tsukada K, Nakahara N, Tsuno T, Osawa H, Kuno T, Fujita M, Hatano M, Yoshida J. Endou M, et al. Int J Mol Med. 2005 Feb;15(2):277-83. Int J Mol Med. 2005. PMID: 15647844
• [Chemoradiation therapy and immunotherapy for pancreatic cancer].

  Egawa S, Motoi F, Fukuyama S, Sunamura M, Unno M. Egawa S, et al. Nihon Rinsho. 2006 Jan;64 Suppl 1:258-63. Nihon Rinsho. 2006. PMID: 16457262 Review. Japanese. No abstract available.
• Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth.

  Vernejoul F, Ghénassia L, Souque A, Lulka H, Drocourt D, Cordelier P, Pradayrol L, Pyronnet S, Buscail L, Tiraby G. Vernejoul F, et al. Mol Ther. 2006 Dec;14(6):758-67. doi: 10.1016/j.ymthe.2006.07.010. Epub 2006 Sep 25. Mol Ther. 2006. PMID: 17000136
• Potential of adenovirus-mediated REIC/Dkk-3 gene therapy for use in the treatment of pancreatic cancer.

  Uchida D, Shiraha H, Kato H, Nagahara T, Iwamuro M, Kataoka J, Horiguchi S, Watanabe M, Takaki A, Nouso K, Nasu Y, Yagi T, Kumon H, Yamamoto K. Uchida D, et al. J Gastroenterol Hepatol. 2014 May;29(5):973-83. doi: 10.1111/jgh.12501. J Gastroenterol Hepatol. 2014. PMID: 24372695
• [New horizon of the treatment of pancreatic cancer].

  Matsuno S. Matsuno S. Nihon Shokakibyo Gakkai Zasshi. 2004 Dec;101(12):1281-7. Nihon Shokakibyo Gakkai Zasshi. 2004. PMID: 15651389 Review. Japanese. No abstract available.